Cell Isolation Market Size Cross to Revenue US$ 24.6 Billion by 2028 | CAGR of 15.65%

PRESS RELEASE
Published April 11, 2023

According to the latest report by IMARC Group “Cell Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global cell isolation market size reached US$ 10.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2027, exhibiting a growth rate (CAGR) of 15.65% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Cell Isolation Market

Cell isolation, also known as cell separation, identifies, isolates and separates targeted cells from a heterogeneous mixture of a cell population. This process helps minimize experimental complexity, reduce the interference from other cell types, and diagnose diseases, cellular research and therapies. In recent years, cell separation has gained prominence as it plays a vital role in therapeutic protein production, in-vitro diagnostics and biologics designing.

Request for a free sample copy of this report: https://www.imarcgroup.com/cell-isolation-market/requestsample

Cell Isolation Market Trends and Drivers:

The global cell isolation market is primarily driven by the expanding medical and pharmaceutical industry. Due to this, pharmaceutical manufacturers are using cell isolation technologies to develop drugs with improved efficacies. In addition, they are utilized to develop novel cell therapies and cell-based treatments for various chronic medical ailments. Besides this, with the onset of coronavirus disease (COVID-19), there has been rapid development of novel vaccines, therapies, and testing kits. This has escalated the demand for cell isolation tools for diagnostics and research activities. Moreover, increasing investments in research and development (R&D) by biotechnology and biopharmaceutical companies to manufacture advanced biologics, such as monoclonal antibodies and vaccines, provide a positive outlook to the market in the near future.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Technique:

  • Centrifugation
  • Surface Marker
  • Filtration

Breakup by Cell Type:

  • Human Cells
  • Animal Cells

Breakup by Product:

  • Consumables
    • Reagents, Kits, Media and Sera
    • Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Flow Cytometers
    • Filtration Systems
    • Magnetic-activated Cell Separator Systems

Breakup by Application:

  • Biomolecule Isolation
  • Therapeutics
  • Stem Cell Research
  • Cancer Research
  • Tissue Regeneration
  • In-Vitro Diagnostics

Breakup by End Use:

  • Biotechnology and Biopharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Alfa Laval AB
  • Becton Dickinson and Company
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • General Electric Company
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
  • Roche Holding AG
  • STEMCELL Technologies Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=3942&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal

IMARC